RMTI
Rockwell Medical, Inc.NASDAQHealthcare$0.96+0.84%ClosedMarket Cap: $38.0M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
1.03
P/S
0.55
EV/EBITDA
9982.60
DCF Value
$690.62
FCF Yield
-3.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
16.9%
Operating Margin
-6.8%
Net Margin
-7.7%
ROE
-15.6%
ROA
-9.3%
ROIC
-9.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $18.3M | 21.1% | $-398.0K | $-554.0K | $-0.01 | — |
| FY 2025 | $69.3M | 16.9% | $-4.7M | $-5.3M | $-0.15 | — |
| Q3 2025 | $15.9M | 14.3% | $-1.6M | $-1.8M | $-0.05 | — |
| Q2 2025 | $16.1M | 15.6% | $-1.3M | $-1.5M | $-0.04 | — |
| Q1 2025 | $18.9M | 16.1% | $-1.4M | $-1.5M | $-0.04 | — |
| Q4 2024 | $24.7M | 14.7% | $-519.0K | $-756.0K | $-0.02 | — |
| FY 2024 | $101.5M | 17.2% | $608.0K | $-480.0K | $-0.03 | — |
| Q3 2024 | $28.3M | 22.0% | $1.9M | $1.7M | $0.05 | — |
| Q2 2024 | $25.8M | 17.6% | $515.0K | $343.0K | $0.01 | — |
| Q1 2024 | $22.7M | 13.5% | $-1.3M | $-1.7M | $-0.06 | — |
| Q4 2023 | $22.1M | 13.0% | $-547.0K | $-1.5M | $-0.05 | — |
| FY 2023 | $83.6M | 10.4% | $-6.7M | $-8.4M | $-0.36 | — |